Lorger, Anna
Luft, Nikolaus
Mayer, Wolfgang J.
Priglinger, Siegfried G.
Dirisamer, Martin
Funding for this research was provided by:
Ludwig-Maximilians-Universität München
Article History
Received: 13 June 2023
Accepted: 8 February 2024
First Online: 7 March 2024
Competing interests
: S. Priglinger: Novartis Pharma GmbH advisory board/honoraria. Pharma Allergan advisory board/honoraria. Zeiss advisory board/honoraria. BVI advisory board/honoraria. Bayer advisory board/honoraria. Alcon advisory board/honoraria. B&L advisory board/honoraria. Allergan advisory board/honoraria. Roche advisory board/honoraria. Oertli honoraria. All other authors: None.